Literature DB >> 7668904

Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis.

J Lewthwaite1, S Blake, R C Thompson, T E Hardingham, B Henderson.   

Abstract

OBJECTIVE: To determine if the administration of interleukin-1 receptor antagonist (IL-1ra) to animals with established antigen induced arthritis had any beneficial effects on the synovitis and cartilage destruction.
METHODS: Antigen induced arthritis was induced in New Zealand White rabbits, and after two weeks IL-1ra was administered every six hours over a 72 hour period. Animals were then killed and joint tissues examined for the degree of synovitis, synovial fibrosis, and cartilage damage.
RESULTS: The response of the arthritis to the treatment was minor in terms of joint swelling, leucocyte accumulation, or cartilage proteoglycan loss. However, the synovial fibrosis was not only halted by administration of IL-1ra, but reversed. The inflamed synovial linings of IL-1ra treated animals showed a significant loss of synovial collagen content and a reappearance of the synovial fat spaces which are prominent in the normal synovial lining.
CONCLUSION: This study shows that IL-1ra has potent antifibrotic activity and suggests the use of this agent for the reversal of the fibroproliferative process which is so important in the pathology of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668904      PMCID: PMC1009941          DOI: 10.1136/ard.54.7.591

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  SIRIUS RED F3BA AS A STAIN FOR CONNECTIVE TISSUE.

Authors:  F SWEAT; H PUCHTLER; S I ROSENTHAL
Journal:  Arch Pathol       Date:  1964-07

2.  Cartilage proteoglycan depletion in acute and chronic antigen-induced arthritis.

Authors:  E R Pettipher; B Henderson; T Hardingham; A Ratcliffe
Journal:  Arthritis Rheum       Date:  1989-05

3.  Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.

Authors:  A Ratcliffe; M Doherty; R N Maini; T E Hardingham
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

4.  Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit.

Authors:  B Henderson; F M Rowe; C R Bird; A J Gearing
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

Review 5.  Determination of hydroxyproline.

Authors:  H Stegemann; K Stalder
Journal:  Clin Chim Acta       Date:  1967-11       Impact factor: 3.786

6.  Quantitative histological analysis of antigen-induced arthritis in the rabbit.

Authors:  J C Edwards; N Read; B Trefty; J Coulstock; B Henderson
Journal:  Br J Exp Pathol       Date:  1988-10

Review 7.  The application of quantitative cytochemistry to the study of diseases of the connective tissues.

Authors:  B Henderson
Journal:  Prog Histochem Cytochem       Date:  1983

8.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Evidence for cell division in synoviocytes in acutely inflamed rabbit joints.

Authors:  B Henderson; L E Glynn; L Bitensky; J Chayen
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

10.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; Y Kapanci; P Vassalli
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  5 in total

1.  Low-Level Laser Therapy Prevents Treadmill Exercise-Induced Progression of Arthrogenic Joint Contracture Via Attenuation of Inflammation and Fibrosis in Remobilized Rat Knees.

Authors:  Akinori Kaneguchi; Junya Ozawa; Kengo Minamimoto; Kaoru Yamaoka
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  A new treatment for knee osteoarthritis: Clinical evidence for the efficacy of Arthrokinex™ autologous conditioned serum.

Authors:  Angelique Barreto; Timothy R Braun
Journal:  J Orthop       Date:  2016-10-25

3.  Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis.

Authors:  N P Barlo; C H M van Moorsel; N M Korthagen; M Heron; G T Rijkers; H J T Ruven; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 4.  New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options.

Authors:  Martin K Lotz; Virginia B Kraus
Journal:  Arthritis Res Ther       Date:  2010-06-28       Impact factor: 5.156

5.  A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.

Authors:  Jean-Noel Gouze; Elvire Gouze; Glyn D Palmer; Victor S Liew; Arnulf Pascher; Oliver B Betz; Thomas S Thornhill; Christopher H Evans; Alan J Grodzinsky; Steven C Ghivizzani
Journal:  Arthritis Res Ther       Date:  2003-08-01       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.